α-细辛脑注射液治疗新生儿感染性肺炎的疗效分析

Analysis of curative effect of asarone on the treatment of infectious pneumonia in the newborn

目的:探讨α-细辛脑注射液治疗新生儿感染性肺炎的疗效和安全性.方法:2003年1～6月住院的新生儿感染性肺炎48例为对照组,2004年1～6月住院的新生儿感染性肺炎45例为治疗组.两组均采取常规治疗,治疗组加用α-细辛脑针05～1 mg/(kg·d).结果:治疗组肺部啰音消失时间、住院时间、需人工吸痰次数均较对照组显著减少(P＜0.01).观察过程中未发现与α-细辛脑相关的不良反应.结论:α-细辛脑治疗新生儿感染性肺炎具有显著的疗效和较好的安全性.

Objeetive: To investigate the clinical effect and its safety of asarone on the treatment in the neonates with infectious pneumonia. Methods: Forty-eight cases of infectious pneumonia in the newborn admitted from January to June, 2003 were adopted as the control, and other forty-five cases of infectious pneumonia of the newborn admitted from January to June, 2004 were adopted as the treatment group. Both receive routine therapy with exception that additional asarone 0.5 ~ 1 mg/(kg·d) were used in the treatment group. Results: Days of physical signs of lung and hospitalization and demand of sucking phlegm in therapy group were significantly less than those in control group (P < 0.01). Conclusion: It's significantly effective and safe to use asarone in treatment of neonates with infectious pneumonia.